SOTAC
Invest Now
Sotac Pharmaceuticals Ltd Share Price
₹119.20 -6.2 (-4.94%)
21 Nov, 2024 20:49
Start SIP in SOTAC
Start SIPPerformance
- Low
- ₹119
- High
- ₹119
- 52 Week Low
- ₹87
- 52 Week High
- ₹203
- Open Price₹119
- Previous Close₹125
- Volume1,200
Investment Returns
- Over 1 Month -13.12%
- Over 3 Month -18.36%
- Over 6 Month -3.56%
- Over 1 Year -3.05%
Smart Investing Starts Here Start SIP with Sotac Pharmaceuticals Ltd for Steady Growth!
Sotac Pharmaceuticals Ltd Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 29.5
- PEG Ratio
- -
- Market Cap Cr
- 132
- P/B Ratio
- 2.7
- Average True Range
- 5.45
- EPS
- 4.16
- Dividend Yield
- 0
- MACD Signal
- -5.87
- RSI
- 39.51
- MFI
- 28.77
Sotac Pharmaceuticals Ltd Financials
Sotac Pharmaceuticals Ltd Technicals
EMA & SMA
Current Price
₹119.20
-6.2
(-4.94%)
- Bullish Moving Average 0
- Bearish Moving Average 16
- 20 Day
- ₹130.60
- 50 Day
- ₹137.56
- 100 Day
- ₹137.44
- 200 Day
- ₹133.39
Resistance and Support
119.2
- R3 119.20
- R2 119.20
- R1 119.20
- S1 119.20
- S2 119.20
- S3 119.20
Sotac Pharmaceuticals Ltd Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-10-29 | Quarterly Results | |
2024-08-13 | Quarterly Results | |
2024-05-17 | Audited Results & Others | To consider other business matters |
2023-11-06 | Quarterly Results | |
2023-05-29 | Audited Results |
Sotac Pharmaceuticals Ltd F&O
About Sotac Pharmaceuticals Ltd
- NSE Symbol
- SOTAC
- BSE Symbol
- Chairman & Managing Director
- Mr. Sharadkumar Dashrathbhai Patel
- ISIN
- INE0O2D01012
Similar Stocks to Sotac Pharmaceuticals Ltd
Sotac Pharmaceuticals Ltd FAQs
Sotac Pharmaceuticals Ltd share price is ₹119 As on 21 November, 2024 | 20:35
The Market Cap of Sotac Pharmaceuticals Ltd is ₹131.7 Cr As on 21 November, 2024 | 20:35
The P/E ratio of Sotac Pharmaceuticals Ltd is 29.5 As on 21 November, 2024 | 20:35
The PB ratio of Sotac Pharmaceuticals Ltd is 2.7 As on 21 November, 2024 | 20:35
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.